Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours Β· Estimated delivery Aug 20 - Aug 25
All content and information provided are for educational and research reference purposes only
Treat BPC-157 as investigational
Across most animal and human studies, two primary routes dominate [1]: Subcutaneous injection : Used in numerous rodent studies (typically 0.110 g/mouse/day) and in human trials (commonly 0.51 mg/day), especially in circadian and immune studies
Prepare a clean, well-lit workspace with all supplies within reach
Through the presence of VEGFR 2 receptors as a growth factor, growth hormone receptors, VEGFR2-AKT-eNOS, ERK , FAK-paxillin, FoxO3a, p-AKT, p-mTOR, and p-GSK-3 pathways, and characteristic loops, the level of pro-inflammatory cytokines is reduced, thereby exhibiting protective effects in the event of inflammation throughout the digestive system
-20C, 1 month (sealed storage, away from moisture and light) Solvent & Solubility In Vitro : H 2 O : 50 mg/mL ( 128.09 mM ) * "" means soluble, but saturation unknown
US$ 21.00
US$ 29.10
US$ 22.10
US$ 25.15
US$ 21.13
US$ 29.71